DALI Medical Devices
Yavne, Israel· Est.
Innovative Israeli injector and safety‑needle developer enabling painless self‑administration of biologics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Innovative Israeli injector and safety‑needle developer enabling painless self‑administration of biologics.
OncologyImmunologyEndocrinologyChronic Disease Management
Technology Platform
Integrated safety‑needle and autoinjector systems combined with IoT connectivity for real‑time monitoring of self‑injection therapy.
Opportunities
Expansion of IoT‑connected injection devices and strategic co‑development with pharma for emerging biologics present strong growth avenues.
Risk Factors
Regulatory hurdles, adoption barriers in entrenched markets, and reliance on a few large pharma partners could limit scaling.
Competitive Landscape
Competes with Becton Dickinson, West Pharmaceutical Services, Ypsomed, etc.; DALI differentiates via integrated safety‑needle design and digital connectivity.